Alerts will be sent to your verified email
Verify Email
AARTIDRUGS
|
Aarti Drugs
|
SMS Pharmaceuticals
|
Morepen Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
APIs Production Capacity
|
45511.0 MTPA | n/a | n/a |
|
R&D as a % of Total Sales
|
1.93 % | 2.4 % | 0.87 % |
|
Financials
|
|||
|
5 yr Average ROE
|
18.02 % | 9.71 % | 13.43 % |
|
5yr average Equity Multiplier
|
1.97 | 1.92 | 1.68 |
|
5yr Average Asset Turnover Ratio
|
1.09 | 0.64 | 1.29 |
|
5yr Avg Net Profit Margin
|
8.24 % | 7.52 % | 5.93 % |
|
Price to Book
|
2.19 | 4.48 | 2.34 |
|
P/E
|
17.43 | 34.55 | 30.69 |
|
5yr Avg Cash Conversion Cycle
|
79.88 Days | 95.74 Days | 12.78 Days |
|
Inventory Days
|
69.48 Days | 117.18 Days | 54.64 Days |
|
Days Receivable
|
111.3 Days | 94.73 Days | 65.45 Days |
|
Days Payable
|
97.75 Days | 94.13 Days | 96.29 Days |
|
5yr Average Interest Coverage Ratio
|
9.61 | 4.95 | 39.11 |
|
5yr Avg ROCE
|
21.16 % | 12.07 % | 15.77 % |
|
5yr Avg Operating Profit Margin
|
14.01 % | 17.65 % | 8.68 % |
|
5 yr average Debt to Equity
|
0.46 | 0.54 | 0.04 |
|
5yr CAGR Net Profit
|
-9.72 % | 2.03 % | 3.98 % |
|
5yr Average Return on Assets
|
9.12 % | 4.9 % | 7.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.03 % | 68.07 % | 35.65 % |
|
Share Pledged by Promoters
|
2.47 % | 17.99 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.55 % | 3.78 % | -2.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
6.13 % | 2.96 % | 0.0 |
|
Aarti Drugs
|
SMS Pharmaceuticals
|
Morepen Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|